Genomic and Molecular Profiling Predicts Response to Temozolomide in Melanoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-1916
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Molecular Profiling of the €œplexinome” in Melanoma and Pancreatic Cancer

Human Mutation
Genetics
2009English

CTLA4 Methylation Predicts Response to Anti–PD-1 and Anti–CTLA-4 Immunotherapy in Melanoma Patients

JCI insight
Medicine
2018English

Metabolomic Profiling to Identify Molecular Biomarkers of Cellular Response to Methotrexate in Vitro

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2019English

A Targeted Genomic Alteration Analysis Predicts Survival of Melanoma Patients Under BRAF Inhibitors

Oncotarget
Oncology
2019English

Celastrol Synergistically Enhances Temozolomide Cytotoxicity in Melanoma Cells

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2009English

Correction: Molecular Profiling Reveals Low- And High-Grade Forms of Primary Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2012English

Molecular Profiling of Pancreatic Cancer Patients—Response

Clinical Cancer Research
Cancer ResearchOncology
2018English

Emotional and Behavioural Reactions to Melanoma Genomic Risk Information

British Journal of Dermatology
DermatologyMedicine
2019English

Genomic Profiling of Decreased DNA Damage Response in Human Squamous Carcinoma Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy